HealthEquity (HQY) Competitors

IQVIA (NYSE:IQV) and HealthEquity (NASDAQ:HQY) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, institutional ownership, risk, profitability, community ranking and earnings.

Is IQV or HQY more profitable?

IQVIA has a net margin of 8.91% compared to HealthEquity's net margin of 8.41%. IQVIA's return on equity of 28.81% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IQVIA	8.91%	28.81%	7.02%
HealthEquity	8.41%	9.70%	6.08%

Which has more risk and volatility, IQV or HQY?

IQVIA has a beta of 1.5, suggesting that its share price is 50% more volatile than the S&P 500. Comparatively, HealthEquity has a beta of 0.62, suggesting that its share price is 38% less volatile than the S&P 500.

Does the media prefer IQV or HQY?

In the previous week, HealthEquity had 4 more articles in the media than IQVIA. MarketBeat recorded 37 mentions for HealthEquity and 33 mentions for IQVIA. IQVIA's average media sentiment score of 1.39 beat HealthEquity's score of 0.33 indicating that IQVIA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IQVIA	28 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
HealthEquity	12 Very Positive mention(s)	2 Positive mention(s)	13 Neutral mention(s)	3 Negative mention(s)	4 Very Negative mention(s)	Neutral

Which has stronger earnings and valuation, IQV or HQY?

IQVIA has higher revenue and earnings than HealthEquity. IQVIA is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IQVIA	$15.41B	2.13	$1.37B	$7.50	24.85
HealthEquity	$1.20B	6.51	$55.71M	$1.09	82.86

Does the MarketBeat Community believe in IQV or HQY?

IQVIA received 144 more outperform votes than HealthEquity when rated by MarketBeat users. However, 70.20% of users gave HealthEquity an outperform vote while only 68.30% of users gave IQVIA an outperform vote.

Company	Underperform	Outperform
IQVIA	Outperform Votes 681 68.30%	Underperform Votes 316 31.70%
HealthEquity	Outperform Votes 537 70.20%	Underperform Votes 228 29.80%

Do insiders and institutionals hold more shares of IQV or HQY?

89.6% of IQVIA shares are owned by institutional investors. Comparatively, 99.6% of HealthEquity shares are owned by institutional investors. 1.6% of IQVIA shares are owned by insiders. Comparatively, 2.2% of HealthEquity shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Do analysts prefer IQV or HQY?

IQVIA currently has a consensus price target of $249.05, suggesting a potential upside of 33.65%. HealthEquity has a consensus price target of $113.69, suggesting a potential upside of 25.88%. Given IQVIA's higher possible upside, analysts plainly believe IQVIA is more favorable than HealthEquity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IQVIA	0 Sell rating(s)	4 Hold rating(s)	16 Buy rating(s)	1 Strong Buy rating(s)	2.86
HealthEquity	0 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.92

Summary

IQVIA beats HealthEquity on 12 of the 19 factors compared between the two stocks.